Bio-Techne (TECH) Revenue — Quarter Ended Dec 31, 2023
Revenue for the quarter was essentially flat compared to the same quarter last year, but declined from the immediately preceding quarter. The sequential decrease reflects a continuation of the lower revenue level seen in the prior quarter relative to earlier periods.
Key takeaway
Quarter ended Dec 31, 2023 · FY2024 Q2
Revenue for the quarter was essentially flat compared to the same quarter last year, but declined from the immediately preceding quarter. The sequential decrease reflects a continuation of the lower revenue level seen in the prior quarter relative to earlier periods.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$272.6M
Revenue reported for this quarter.
Quarter-over-quarter
-1.6%
Change from the immediately preceding quarter.
Year-over-year
+0.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$1.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2023 | $294.1M | +1.3% |
| Jun 30, 2023 | $301.3M | +4.5% |
| Sep 30, 2023 | $276.9M | +2.7% |
| Dec 31, 2023 | $272.6M | +0.4% |
Revenue performance
Reported revenue moved lower sequentially, following a pattern of declining quarterly figures over the past two quarters. The year-over-year comparison showed a marginal increase.
Quarterly comparison
Compared to the immediately preceding quarter, revenue decreased. Relative to the same quarter one year earlier, revenue was slightly higher.
What to watch
The sequential revenue decline, despite a modest year-over-year gain, may warrant attention to the sustainability of recent demand trends.